课题基金 / 基金详情

Regulation of glycolipid expression and its disorder

Regulation of glycolipid expression and its disorder
糖脂表达的调控及其紊乱
批准号:
03454157
负责人:
NAGAI Yoshitaka
金额:
$4.29万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

NAGAI Yoshitaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Isolation and characterization of sialyltransferases which synthesize bioactive gangliosides were carried out.[1] High sensitive and non-radioactive assay method for sialyltransferases: To improve the assay method of ganglioside sialyltransferase activity, we used pryridylamine-labeled oligosaccharides as substrate.These fluorescent substrates were well separated in HPLC and were applicable in sialyltransferase assay. Ganglioside was digested by endoglycoceramidase and released oligosaccharide was labeled by pyridylamine. Sialyltransferase was partially purified from membrane fraction of rat liver Golgi apparatus. Pyridylamine labelled GM3-oligosaccharide was good substrate for GD3 synthase as native GM3 gangliosede. But, Pyridylamine labelled oligosaccharide of CDH was poor substrate for GM3 synthase. Detergent requirment for full activity of GD3 synthase was reduced suggesting that detergent act in part not only as solubilizer of enzyme but also raise availability of glycolipids[2] P … More hoto-affinity labeling of sialyltransferase: Photoactive diazilin derivatives of lactosylceramide and CMP-NeuAc which were the substrate of sialyltransferase (GM3 synthase). These compounds were good substrates and had high affinity to GM3 synthase, respectively. Some molecules were specifically labeled by these compounds and detected by SDS-PAGE autoradiography.[3] Characterization and biosynthesis of gangliosides in developing Xenopus laevis: Change of ganglioside species during early development of Xenopus laevis were studied. Major ganglioside in oocyte was GalNAc-GM1b. There is two possible pathways for in vivo synthesis of GalNAc-GM1b. UDP-GalNAc : GM1b beta1-3 N-acetylgalactosaminyl transferase activity was only detected in Xenopus membrane fraction. These suggest that GalNAc-GM1b was synthesized via GM1b from gangliotetraosylceramide in Xenopus. Dramatical elevation of level of GalNAc-GM1b and GM3 was observed after fertilization. Several lines of evidence suggest that alpha2-3 sialyltransferase activity was elevated during this stage. Less
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
佐内 豊: "糖脂質糖鎖のがん性変化" 医学と薬学. 26. 983-991 (1991)
Yutaka Sanai:“糖脂糖链的癌变”《医学与药学》26. 983-991 (1991)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Hidari,et al.: "Enzymatic basis ofaccumulation of monosialosylgangliopentaosylceramide in Xenopus laevis oocyte" Eur.J.Biochemistry.
K.Hidari 等人:“非洲爪蟾卵母细胞中单唾液酸神经节五糖神经酰胺积累的酶学基础”Eur.J.Biochemistry。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    Establishment and pathological analyses of transgenic marmoset models of polyglutamine diseases
    • 批准号:
      26670446
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      NAGAI Yoshitaka
    • 依托单位:
    A gain of toxic function hypothesis via accumulated RNA-binding protein and repeat RNA in the pathogenesis of ALS and its validation in vivo
    Therapeutic strategy for the polyglutamine diseases by selective degradation of expanded polyglutamine proteins using polyglutamine-binding pepetides
    • 批准号:
      23390237
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2011
    • 负责人:
      NAGAI Yoshitaka
    • 依托单位:
    Development of a drug for the polyglutamine diseases by molecular design of chemical analogues of the aggregation inhibitor peptide QBP1
    • 批准号:
      22659172
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.11万
    • 财政年份:
      2010
    • 负责人:
      NAGAI Yoshitaka
    • 依托单位:
    海外基金